These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28691)

  • 1. Biological effects of 5-carboxy-2'-deoxyuridine: hydrolysis product of 5-trifluoromethyl-2'-deoxyuridine.
    Clough DW; Wigdahl BL; Parkhurst JR
    Antimicrob Agents Chemother; 1978 Jul; 14(1):126-31. PubMed ID: 28691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapy.
    Cheng YC; Grill S; Ruth J; Bergstrom DE
    Antimicrob Agents Chemother; 1980 Dec; 18(6):957-61. PubMed ID: 6263181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral action and cellular toxicity of four thymidine analogues: 5-ethyl-,5-vinyl-, 5-propyl-, and 5-allyl-2'- deoxyuridine.
    Cheng YC; Domin BA; Sharma RA; Bobek M
    Antimicrob Agents Chemother; 1976 Jul; 10(1):119-22. PubMed ID: 185944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HEp-2 cell- and herpes simplex virus type 1- induced deoxythymidine kinases: inhibition by derivatives of 5-trifluoromethyl-2'-deoxyuridine.
    Wigdahl BL; Parkhurst JR
    Antimicrob Agents Chemother; 1978 Sep; 14(3):470-5. PubMed ID: 213016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine and related analogues: potent and unusually selective antiviral activity of (E)-5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine against herpes simplex virus type 1.
    Bergstrom DE; Ruth JL; Reddy PA; De Clercq E
    J Med Chem; 1984 Mar; 27(3):279-84. PubMed ID: 6321735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxythymidine kinase induced in the HELA TK- cells by herpes simplex virus type I and type II. Substrate specificity and kinetic behavior.
    Cheng YC
    Biochim Biophys Acta; 1976 Dec; 452(2):370-81. PubMed ID: 188465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective antiviral agents. The metabolism of 5-propyl-2'-deoxyuridine and effects on DNA synthesis in herpes simplex virus type 1 infections.
    Ruth JL; Cheng Y
    J Biol Chem; 1982 Sep; 257(17):10261-6. PubMed ID: 6286646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human deoxythymidine kinase II: substrate specificity and kinetic behavior of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia.
    Lee LS; Cheng Yc
    Biochemistry; 1976 Aug; 15(17):3686-90. PubMed ID: 1066165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    De Clercq E; Descamps J; Balzarini J; Fukui T; Allaudeen HS
    Biochem J; 1983 May; 211(2):439-45. PubMed ID: 6307280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of poly(ADP-ribose)polymerase activity by nucleoside analogs of thymidine.
    Pivazyan AD; Birks EM; Wood TG; Lin TS; Prusoff WH
    Biochem Pharmacol; 1992 Sep; 44(5):947-53. PubMed ID: 1530662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
    Fischer PH; Murphy DG; Kawahara R
    Mol Pharmacol; 1983 Jul; 24(1):90-6. PubMed ID: 6408395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of 5-nitro-2'-deoxyuridine.
    Washtien WL; Santi DV
    J Med Chem; 1982 Oct; 25(10):1252-5. PubMed ID: 6183429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxyribosyl exchange reactions leading to the in vivo generation and regeneration of the antiviral agents (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5-ethyl-2'-deoxyuridine and 5-(2-chloroethyl)-2'-deoxyuridine.
    Desgranges C; De Clercq E; Razaka G; Drouillet F; Belloc I; Bricaud H
    Biochem Pharmacol; 1986 May; 35(10):1647-53. PubMed ID: 3011010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
    De Clercq E; Bères J; Bentrude WG
    Mol Pharmacol; 1987 Aug; 32(1):286-92. PubMed ID: 3039343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of treatment with 5-ethyl-2'-deoxyuridine on herpes simplex virus encephalitis in normal and immunosuppressed mice.
    Davis WB; Oakes JE; Taylor JA
    Antimicrob Agents Chemother; 1978 Nov; 14(5):743-8. PubMed ID: 215081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of sister-chromatid exchange by 5-substituted 2'-deoxyuridines.
    Cassiman JJ; de Clercq E; van den Berghe H
    Mutat Res; 1983; 117(3-4):317-27. PubMed ID: 6855788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of herpes simplex virus types 1 and 2 replication in vitro by mercurithio analogs of deoxyuridine.
    Holliday J; Williams MV
    Antiviral Res; 1991 Sep; 16(2):197-203. PubMed ID: 1665962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiviral activity of 5-[(cyanomethylene)oxy]-2'-deoxyuridine.
    Huang GF; Okada M; De Clercq E; Torrence PF
    J Med Chem; 1981 Apr; 24(4):390-3. PubMed ID: 6267280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.